{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:48Z","timestamp":1790985648385,"version":"4.1.0"},"reference-count":157,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.arr.2011.03.001","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T08:41:36Z","timestamp":1300264896000},"page":"453-463","source":"Crossref","is-referenced-by-count":112,"title":["Impact of omega-3 fatty acids in Parkinson's disease"],"prefix":"10.1016","volume":"10","author":[{"given":"M\u00e9lanie","family":"Bousquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Calon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2011.03.001_bib0005","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.20527","article-title":"A systematic review of prevalence studies of dementia in Parkinson's disease","volume":"20","author":"Aarsland","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2011.03.001_bib0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neulet.2008.04.073","article-title":"Reduced numbers of dopamine neurons in the substantia nigra pars compacta and ventral tegmental area of rats fed an n-3 polyunsaturated fatty acid-deficient diet: a stereological study","volume":"438","author":"Ahmad","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2011.03.001_bib0015","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.cellsig.2010.10.020","article-title":"Apoptosis in Parkinson's disease: is p53 the missing link between genetic and sporadic Parkinsonism?","volume":"23","author":"Alves da Costa","year":"2011","journal-title":"Cell. Signal."},{"key":"10.1016\/j.arr.2011.03.001_bib0020","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(10)70213-1","article-title":"Are synucleinopathies prion-like disorders?","volume":"9","author":"Angot","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2011.03.001_bib0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.plefa.2003.12.009","article-title":"Fatty acids and homocysteine levels in patients with recurrent depression: an explorative pilot study","volume":"70","author":"Assies","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.arr.2011.03.001_bib0030","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1523\/JNEUROSCI.1799-06.2006","article-title":"Alpha-synuclein expression modulates microglial activation phenotype","volume":"26","author":"Austin","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2011.03.001_bib0035","doi-asserted-by":"crossref","first-page":"11321","DOI":"10.1073\/pnas.1734008100","article-title":"Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids","volume":"100","author":"Barcelo-Coblijn","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.arr.2011.03.001_bib0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.plipres.2009.07.002","article-title":"Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels","volume":"48","author":"Barcelo-Coblijn","year":"2009","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0045","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1750-3639.2005.tb00513.x","article-title":"Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress","volume":"15","author":"Bazan","year":"2005","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2011.03.001_bib0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00213-005-0059-7","article-title":"Chronic valproate does not alter the kinetics of docosahexaenoic acid within brain phospholipids of the unanesthetized rat","volume":"182","author":"Bazinet","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.arr.2011.03.001_bib0055","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.jcbfm.9600276","article-title":"Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease","volume":"26","author":"Bohnen","year":"2006","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.arr.2011.03.001_bib0060","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.neuint.2009.12.022","article-title":"Cyclooxygenase-2 and n-6 PUFA are lower and DHA is higher in the cortex of fat-1 mice","volume":"56","author":"Boudrault","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2011.03.001_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2008.05.016","article-title":"Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease","volume":"20","author":"Boudrault","year":"2009","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.arr.2011.03.001_bib0070","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.pnpbp.2009.07.018","article-title":"Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model","volume":"33","author":"Bousquet","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.arr.2011.03.001_bib0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1194\/jlr.M011692","article-title":"Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease","volume":"52","author":"Bousquet","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0080","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1096\/fj.07-9677com","article-title":"Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease","volume":"22","author":"Bousquet","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2011.03.001_bib0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2011.03.001_bib0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.plefa.2009.01.004","article-title":"alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans","volume":"80","author":"Brenna","year":"2009","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.arr.2011.03.001_bib0095","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","article-title":"Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein","volume":"22","author":"Cabin","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2011.03.001_bib0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.plefa.2006.05.012","article-title":"Polyunsaturated fatty acids and inflammation","volume":"75","author":"Calder","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.arr.2011.03.001_bib0105","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1503\/cmaj.050663","article-title":"Nonpatentable drugs and the cost of our ignorance","volume":"174","author":"Calon","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.arr.2011.03.001_bib0110","unstructured":"Calon, F. Omega-3 polyunsaturated fatty acids in Alzheimer's disease: key questions and partial answers. Curr. Alzheimer Res., in press."},{"key":"10.1016\/j.arr.2011.03.001_bib0115","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.plefa.2007.10.019","article-title":"Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies","volume":"77","author":"Calon","year":"2007","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.arr.2011.03.001_bib0120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1460-9568.2005.04253.x","article-title":"Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease","volume":"22","author":"Calon","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2011.03.001_bib0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.neuron.2004.08.013","article-title":"Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model","volume":"43","author":"Calon","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2011.03.001_bib0130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/mds.10343","article-title":"Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications","volume":"18","author":"Calon","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2011.03.001_bib0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neures.2008.07.005","article-title":"Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease","volume":"62","author":"Cansev","year":"2008","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0140","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1471-4159.2005.03247.x","article-title":"Fatty acid incorporation is decreased in astrocytes cultured from alpha-synuclein gene-ablated mice","volume":"94","author":"Castagnet","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2011.03.001_bib0145","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1093\/jn\/128.12.2512","article-title":"Dietary fish oil affects monoaminergic neurotransmission and behavior in rats","volume":"128","author":"Chalon","year":"1998","journal-title":"J. Nutr."},{"key":"10.1016\/j.arr.2011.03.001_bib0150","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1471-4159.2010.07116.x","article-title":"Rapid de-esterification and loss of eicosapentaenoic acid from rat brain phospholipids: an intracerebroventricular study","volume":"166","author":"Chen","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2011.03.001_bib0155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1194\/jlr.M700386-JLR200","article-title":"The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations","volume":"49","author":"Chen","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.toxlet.2003.09.009","article-title":"The induction of amyloid precursor protein and alpha-synuclein in rat hippocampal astrocytes by diethyldithiocarbamate and copper with or without glutathione","volume":"146","author":"Cheng","year":"2004","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.arr.2011.03.001_bib0165","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.pnpbp.2008.05.015","article-title":"The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study","volume":"32","author":"Chiu","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.arr.2011.03.001_bib0170","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.febslet.2004.09.038","article-title":"Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein","volume":"576","author":"Choi","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2011.03.001_bib0175","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1080\/07315724.2008.10719743","article-title":"Differences between dietary supplement and prescription drug omega-3 fatty acid formulations: a legislative and regulatory perspective","volume":"27","author":"Collins","year":"2008","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.arr.2011.03.001_bib0180","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/3311","article-title":"Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease","volume":"4","author":"Conway","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2011.03.001_bib0185","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1476-5381.1984.tb16227.x","article-title":"The antidyskinetic action of dihomo-gamma-linolenic acid in the rodent","volume":"83","author":"Costall","year":"1984","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.arr.2011.03.001_bib0190","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-2-14","article-title":"Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition","volume":"2","author":"Croisier","year":"2005","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2011.03.001_bib0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/jn\/127.1.146","article-title":"The majority of dietary linoleate in growing rats is beta-oxidized or stored in visceral fat","volume":"127","author":"Cunnane","year":"1997","journal-title":"J. Nutr."},{"key":"10.1016\/j.arr.2011.03.001_bib0200","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.plipres.2009.04.001","article-title":"Fish, docosahexaenoic acid and Alzheimer's disease","volume":"48","author":"Cunnane","year":"2009","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jad.2008.03.008","article-title":"Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation","volume":"111","author":"da Silva","year":"2008","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.arr.2011.03.001_bib0210","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1212\/01.WNL.0000166038.67153.9F","article-title":"Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study","volume":"64","author":"de Lau","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2011.03.001_bib0215","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neures.2009.11.006","article-title":"Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson's disease","volume":"66","author":"Delattre","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0220","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1046\/j.1471-4159.1996.66041582.x","article-title":"alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex","volume":"66","author":"Delion","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2011.03.001_bib0225","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/jn\/124.12.2466","article-title":"Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats","volume":"124","author":"Delion","year":"1994","journal-title":"J. Nutr."},{"key":"10.1016\/j.arr.2011.03.001_bib0230","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.bbalip.2006.06.006","article-title":"Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats","volume":"1761","author":"DeMar","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.arr.2011.03.001_bib0235","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1471-4159.2005.03258.x","article-title":"alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid","volume":"94","author":"DeMar","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2011.03.001_bib0240","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2004.06.036","article-title":"Docosahexaenoic acid reduces haloperidol-induced dyskinesias in mice: involvement of Nur77 and retinoid receptors","volume":"56","author":"Ethier","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 3","key":"10.1016\/j.arr.2011.03.001_bib0245","doi-asserted-by":"crossref","first-page":"S497","DOI":"10.1002\/mds.22028","article-title":"The history of dopamine and levodopa in the treatment of Parkinson's disease","volume":"23","author":"Fahn","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2011.03.001_bib0250","series-title":"Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","author":"FDA","year":"2005"},{"key":"10.1016\/j.arr.2011.03.001_bib0255","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.plefa.2006.07.006","article-title":"Omega-3 fatty acids and rodent behavior","volume":"75","author":"Fedorova","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.arr.2011.03.001_bib0260","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/archneur.63.10.1402","article-title":"Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial","volume":"63","author":"Freund-Levi","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2011.03.001_bib0265","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ana.410400609","article-title":"Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging","volume":"40","author":"Frey","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2011.03.001_bib0270","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1096\/fj.07-9348com","article-title":"Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain","volume":"22","author":"Fuchs","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2011.03.001_bib0275","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/ajcn\/86.5.1486","article-title":"Prospective study of dietary pattern and risk of Parkinson disease","volume":"86","author":"Gao","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.arr.2011.03.001_bib0280","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.arr.2011.03.001_bib0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11010-008-0008-y","article-title":"The role of alpha-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response","volume":"326","author":"Golovko","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.arr.2011.03.001_bib0290","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neulet.2007.12.031","article-title":"Brain prostaglandin formation is increased by alpha-synuclein gene-ablation during global ischemia","volume":"432","author":"Golovko","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2011.03.001_bib0295","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1021\/bi0600289","article-title":"Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism","volume":"45","author":"Golovko","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2011.03.001_bib0300","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1471-4159.2006.04357.x","article-title":"Alpha-synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids","volume":"101","author":"Golovko","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2011.03.001_bib0305","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11745-010-3486-0","article-title":"Lipid classes and fatty acid patterns are altered in the brain of gamma-synuclein null mutant mice","volume":"46","author":"Guschina","year":"2011","journal-title":"Lipids"},{"key":"10.1016\/j.arr.2011.03.001_bib0310","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12031-007-0050-3","article-title":"A model for fatty acid transport into the brain","volume":"33","author":"Hamilton","year":"2007","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.arr.2011.03.001_bib0315","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.arr.2011.03.001_bib0320","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0169-328X(95)00278-Z","article-title":"Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease","volume":"36","author":"Harrington","year":"1996","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0325","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2011.03.001_bib0330","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2011.03.001_bib0335","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nbd.2008.12.002","article-title":"DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe\/PS1dE9 mice","volume":"33","author":"Hooijmans","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2011.03.001_bib0340","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","article-title":"Identification of two distinct synucleins from human brain","volume":"345","author":"Jakes","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2011.03.001_bib0345","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/CIA.S5231","article-title":"Omega-3 fatty acids: potential role in the management of early Alzheimer's disease","volume":"5","author":"Jicha","year":"2010","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.arr.2011.03.001_bib0350","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuint.2005.12.002","article-title":"Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys","volume":"48","author":"Julien","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2011.03.001_bib0355","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/brain\/124.6.1125","article-title":"Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex","volume":"124","author":"Kaasinen","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.arr.2011.03.001_bib0360","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease","volume":"9","author":"Kehagia","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2011.03.001_bib0365","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1073\/pnas.0402342101","article-title":"Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression","volume":"101","author":"Kitajka","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.arr.2011.03.001_bib0370","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0304-3940(01)02481-8","article-title":"Neither the density nor function of striatal dopamine transporters were influenced by chronic n-3 polyunsaturated fatty acid deficiency in rodents","volume":"321","author":"Kodas","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2011.03.001_bib0375","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2011.03.001_bib0380","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neures.2006.06.010","article-title":"Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction","volume":"56","author":"Kotani","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0385","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2011.03.001_bib0390","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","article-title":"Parkinson's disease. Second of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2011.03.001_bib0395","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2011.03.001_bib0400","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nature05290","article-title":"A century-old debate on protein aggregation and neurodegeneration enters the clinic","volume":"443","author":"Lansbury","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.arr.2011.03.001_bib0405","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00075197-200403000-00008","article-title":"Polyunsaturated fatty acids and gene expression","volume":"7","author":"Lapillonne","year":"2004","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.arr.2011.03.001_bib0410","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1096\/fj.00-0334com","article-title":"Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis","volume":"15","author":"Lee","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2011.03.001_bib0415","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2011.03.001_bib0420","article-title":"The efficacy of omega-3 supplementation for major depression: a randomized controlled trial","author":"Lesperance","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.arr.2011.03.001_bib0425","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2011.03.001_bib0430","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/CIRCULATIONAHA.106.176158","article-title":"Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee","volume":"114","author":"Lichtenstein","year":"2006","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.arr.2011.03.001_bib0435","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1002\/mds.22786","article-title":"The nonmotor symptoms of Parkinson's disease\u2014an overview","volume":"25","author":"Lim","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2011.03.001_bib0440","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/S1368980009005679","article-title":"n-3 Fatty acid intake from marine food products among Quebecers: comparison to worldwide recommendations","volume":"13","author":"Lucas","year":"2010","journal-title":"Public Health Nutr."},{"key":"10.1016\/j.arr.2011.03.001_bib0445","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1054\/plef.2002.0435","article-title":"Depression and adipose essential polyunsaturated fatty acids","volume":"67","author":"Mamalakis","year":"2002","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.arr.2011.03.001_bib0450","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1176\/appi.ajp.160.5.996","article-title":"A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression","volume":"160","author":"Marangell","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.arr.2011.03.001_bib0455","doi-asserted-by":"crossref","first-page":"43807","DOI":"10.1074\/jbc.M305841200","article-title":"Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression","volume":"278","author":"Marcheselli","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2011.03.001_bib0460","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1194\/jlr.M600150-JLR200","article-title":"Rat long-chain acyl-CoA synthetase mRNA, protein, and activity vary in tissue distribution and in response to diet","volume":"47","author":"Mashek","year":"2006","journal-title":"J. Lipid Res."},{"issue":"Suppl. 1","key":"10.1016\/j.arr.2011.03.001_bib0465","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson's disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.arr.2011.03.001_bib0470","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jad.2010.03.015","article-title":"Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder","volume":"126","author":"McNamara","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.arr.2011.03.001_bib0475","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0920-9964(95)00084-4","article-title":"Schizophrenic symptoms and dietary intake of n-3 fatty acids","volume":"18","author":"Mellor","year":"1995","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0480","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/exnr.1998.7008","article-title":"Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease","volume":"156","author":"Miller","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2011.03.001_bib0485","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4088\/JCP.08m04603","article-title":"A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder","volume":"70","author":"Mischoulon","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.arr.2011.03.001_bib0490","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.lfs.2010.09.003","article-title":"Regional differences of the mouse brain in response to an alpha-linolenic acid-restricted diet: neurotrophin content and protein kinase activity","volume":"87","author":"Miyazawa","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.arr.2011.03.001_bib0495","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(99)00463-2","article-title":"Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease","volume":"270","author":"Mogi","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2011.03.001_bib0500","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.neuint.2009.10.015","article-title":"Modification of brain lipids but not phenotype in alpha-synucleinopathy transgenic mice by long-term dietary n-3 fatty acids","volume":"56","author":"Muntane","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2011.03.001_bib0505","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/mnfr.200900157","article-title":"Dietary intake and depressive symptoms: a systematic review of observational studies","volume":"54","author":"Murakami","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0510","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1523\/JNEUROSCI.20-09-03214.2000","article-title":"Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2011.03.001_bib0515","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.1021\/bi047292r","article-title":"Brain arachidonic acid incorporation is decreased in heart fatty acid binding protein gene-ablated mice","volume":"44","author":"Murphy","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2011.03.001_bib0520","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/bi0487140","article-title":"Fluorescence studies suggest a role for alpha-synuclein in the phosphatidylinositol lipid signaling pathway","volume":"44","author":"Narayanan","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.arr.2011.03.001_bib0525","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1074\/jbc.274.14.9843","article-title":"Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation","volume":"274","author":"Narhi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2011.03.001_bib0530","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01753889","article-title":"Differences in rates of incorporation of intravenously injected radiolabeled fatty acids into phospholipids of intracerebrally implanted tumor and brain in awake rats","volume":"12","author":"Nariai","year":"1994","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.arr.2011.03.001_bib0535","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1176\/appi.ajp.159.3.477","article-title":"Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder","volume":"159","author":"Nemets","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.arr.2011.03.001_bib0540","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm.2165","article-title":"Missing pieces in the Parkinson's disease puzzle","volume":"16","author":"Obeso","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2011.03.001_bib0545","doi-asserted-by":"crossref","first-page":"12571","DOI":"10.1073\/pnas.0906759106","article-title":"Is Parkinson's disease a prion disorder?","volume":"106","author":"Olanow","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.arr.2011.03.001_bib0550","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMoa0809335","article-title":"A double-blind, delayed-start trial of rasagiline in Parkinson's disease","volume":"361","author":"Olanow","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2011.03.001_bib0555","first-page":"735","article-title":"The emerging role of docosahexaenoic acid in neuroinflammation","volume":"9","author":"Orr","year":"2008","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.arr.2011.03.001_bib0560","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.neuint.2009.04.018","article-title":"Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood\u2013brain barrier: an in situ cerebral perfusion study","volume":"55","author":"Ouellet","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.arr.2011.03.001_bib0565","doi-asserted-by":"crossref","DOI":"10.1007\/s12640-011-9238-y","article-title":"The effect of docosahexaenoic acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B","author":"Ozsoy","year":"2011","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0570","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00001756-199902250-00021","article-title":"Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra","volume":"10","author":"Parain","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.arr.2011.03.001_bib0575","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jmb.2004.02.014","article-title":"Structural determinants of PLD2 inhibition by alpha-synuclein","volume":"337","author":"Payton","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.arr.2011.03.001_bib0580","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1523\/JNEUROSCI.22-08-03090.2002","article-title":"A role for alpha-synuclein in the regulation of dopamine biosynthesis","volume":"22","author":"Perez","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2011.03.001_bib0585","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00005072-199305000-00001","article-title":"Pathology and biology of the Lewy body","volume":"52","author":"Pollanen","year":"1993","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2011.03.001_bib0590","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF02536034","article-title":"Mechanisms of free radical oxidation of unsaturated lipids","volume":"30","author":"Porter","year":"1995","journal-title":"Lipids"},{"key":"10.1016\/j.arr.2011.03.001_bib0595","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2011.03.001_bib0600","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.mp.4001888","article-title":"n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism","volume":"12","author":"Rao","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2011.03.001_bib0605","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0022-2275(20)31629-1","article-title":"Delivery and turnover of plasma-derived essential PUFAs in mammalian brain","volume":"42","author":"Rapoport","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0610","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/01.WNL.0000149403.14458.7F","article-title":"The role of radiotracer imaging in Parkinson disease","volume":"64","author":"Ravina","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2011.03.001_bib0615","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U","article-title":"alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes","volume":"62","author":"Richter-Landsberg","year":"2000","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0620","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12031-010-9439-5","article-title":"Membrane lipid modification by docosahexaenoic acid (DHA) promotes the formation of alpha-synuclein inclusion bodies immunopositive for SUMO-1 in oligodendroglial cells after oxidative stress","volume":"43","author":"Riedel","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.arr.2011.03.001_bib0625","first-page":"618","article-title":"Fatty acid and phospholipid species composition of rat tissues after a fish oil diet","volume":"19","author":"Salem","year":"1989","journal-title":"Adv. Prostaglandin Thromboxane Leukot. Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0630","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s11745-001-0805-6","article-title":"Mechanisms of action of docosahexaenoic acid in the nervous system","volume":"36","author":"Salem","year":"2001","journal-title":"Lipids"},{"key":"10.1016\/j.arr.2011.03.001_bib0635","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ana.20738","article-title":"Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys","volume":"59","author":"Samadi","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2011.03.001_bib0640","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(10)60445-X","article-title":"Cardiovascular effects of marine omega-3 fatty acids","volume":"376","author":"Saravanan","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2011.03.001_bib0645","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1073\/pnas.95.7.4013","article-title":"Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons","volume":"95","author":"Saucedo-Cardenas","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.arr.2011.03.001_bib0650","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nrneurol.2010.52","article-title":"Molecular and clinical prodrome of Parkinson disease: implications for treatment","volume":"6","author":"Schapira","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2011.03.001_bib0655","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-0082(96)00015-9","article-title":"Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae","volume":"49","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2011.03.001_bib0660","first-page":"1694","article-title":"Loss of dopamine transporter binding in Parkinson's disease follows a single exponential rather than linear decline","volume":"45","author":"Schwarz","year":"2004","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2011.03.001_bib0665","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.prostaglandins.2004.03.005","article-title":"Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis","volume":"73","author":"Serhan","year":"2004","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"10.1016\/j.arr.2011.03.001_bib0670","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mds.1099","article-title":"Comorbidity of the nonmotor symptoms of Parkinson's disease","volume":"16","author":"Shulman","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2011.03.001_bib0675","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.biopha.2006.07.080","article-title":"Evolutionary aspects of diet, the omega-6\/omega-3 ratio and genetic variation: nutritional implications for chronic diseases","volume":"60","author":"Simopoulos","year":"2006","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2011.03.001_bib0680","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.arr.2011.03.001_bib0685","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tibs.2007.09.013","article-title":"Nutritionally essential fatty acids and biologically indispensable cyclooxygenases","volume":"33","author":"Smith","year":"2008","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.arr.2011.03.001_bib0690","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0014-5793(00)01563-5","article-title":"Chaperone-like activity of synucleins","volume":"474","author":"Souza","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2011.03.001_bib0695","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1388-1981(00)00077-9","article-title":"Metabolism of highly unsaturated n-3 and n-6 fatty acids","volume":"1486","author":"Sprecher","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"Suppl.","key":"10.1016\/j.arr.2011.03.001_bib0700","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1007\/BF02562271","article-title":"Regulation of the biosynthesis of 22:5n-6 and 22:6n-3: a complex intracellular process","volume":"34","author":"Sprecher","year":"1999","journal-title":"Lipids"},{"key":"10.1016\/j.arr.2011.03.001_bib0705","doi-asserted-by":"crossref","first-page":"38115","DOI":"10.1074\/jbc.M106326200","article-title":"Peroxisomal straight-chain Acyl-CoA oxidase and D-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis","volume":"276","author":"Su","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2011.03.001_bib0710","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1471-4159.1964.tb06735.x","article-title":"The distribution of lipids in the human nervous system. I. Analytical procedure. Lipids of foetal and newborn brain","volume":"11","author":"Svennerholm","year":"1964","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2011.03.001_bib0715","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2478\/v10042-010-0047-6","article-title":"The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease","volume":"48","author":"Tanriover","year":"2010","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/j.arr.2011.03.001_bib0720","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2011.03.001_bib0725","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/archpsyc.58.5.512","article-title":"Fish consumption, depression, and suicidality in a general population","volume":"58","author":"Tanskanen","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.arr.2011.03.001_bib0730","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0006-8993(95)00674-F","article-title":"Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine","volume":"692","author":"Thibaut","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0735","first-page":"R1273","article-title":"Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain","volume":"267","author":"Thies","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.arr.2011.03.001_bib0740","first-page":"678","article-title":"Essential fatty acids and neuroleptic drug induced tardive dyskinesia: preliminary clinical observations","volume":"12","author":"Vaddadi","year":"1984","journal-title":"IRCS Med. Sci."},{"key":"10.1016\/j.arr.2011.03.001_bib0745","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0165-1781(89)90146-7","article-title":"A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia","volume":"27","author":"Vaddadi","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0750","doi-asserted-by":"crossref","first-page":"22254","DOI":"10.1074\/jbc.M703169200","article-title":"Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products","volume":"282","author":"Wada","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2011.03.001_bib0755","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1194\/jlr.M400335-JLR200","article-title":"Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases","volume":"46","author":"Wang","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0760","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0304-3940(03)00097-1","article-title":"Attenuation of dopamine transporter activity by alpha-synuclein","volume":"340","author":"Wersinger","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2011.03.001_bib0765","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","article-title":"Evolution of cognitive dysfunction in an incident Parkinson's disease cohort","volume":"130","author":"Williams-Gray","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.arr.2011.03.001_bib0770","doi-asserted-by":"crossref","first-page":"10345","DOI":"10.1073\/pnas.90.21.10345","article-title":"Modulation of learning, pain thresholds, and thermoregulation in the rat by preparations of free purified alpha-linolenic and linoleic acids: determination of the optimal omega 3-to-omega 6 ratio","volume":"90","author":"Yehuda","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.arr.2011.03.001_bib0775","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/156720510791050911","article-title":"Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline","volume":"7","author":"Yurko-Mauro","year":"2010","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0780","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-2275(20)32071-X","article-title":"Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids","volume":"41","author":"Zimmer","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.arr.2011.03.001_bib0785","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(00)00950-2","article-title":"Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex","volume":"284","author":"Zimmer","year":"2000","journal-title":"Neurosci. Lett."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163711000225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163711000225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T10:55:58Z","timestamp":1637405758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163711000225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":157,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1568163711000225"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2011.03.001","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}